PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.85%
Revenue growth above 1.5x ADI's 10.56%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.82%
Gross profit growth 1.25-1.5x ADI's 14.87%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
23.29%
EBIT growth similar to ADI's 21.83%. Walter Schloss might infer both firms share similar operational efficiencies.
31.03%
Operating income growth 1.25-1.5x ADI's 21.83%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-1.96%
Negative net income growth while ADI stands at 35.48%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.65%
Negative EPS growth while ADI is at 34.25%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.03%
Negative diluted EPS growth while ADI is at 34.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.11%
Share count expansion well above ADI's 0.16%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.22%
Diluted share count expanding well above ADI's 0.19%. Michael Burry would fear significant dilution to existing owners' stakes.
0.13%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-16.10%
Negative OCF growth while ADI is at 29.87%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-18.43%
Negative FCF growth while ADI is at 45.41%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
31.77%
10Y revenue/share CAGR at 50-75% of ADI's 63.37%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
23.77%
5Y revenue/share CAGR at 50-75% of ADI's 43.54%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-0.08%
Negative 3Y CAGR while ADI stands at 1.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
41.36%
10Y OCF/share CAGR under 50% of ADI's 100.30%. Michael Burry would worry about a persistent underperformance in cash creation.
13.88%
Below 50% of ADI's 140.56%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-9.71%
Negative 3Y OCF/share CAGR while ADI stands at 252.35%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
103.37%
Net income/share CAGR above 1.5x ADI's 46.91% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
88.52%
5Y net income/share CAGR above 1.5x ADI's 42.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
13.44%
Below 50% of ADI's 424.14%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
7.90%
Below 50% of ADI's 213.70%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.15%
Negative 5Y equity/share growth while ADI is at 97.90%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-18.37%
Negative 3Y equity/share growth while ADI is at 18.22%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
644.90%
10Y dividend/share CAGR above 1.5x ADI's 180.36%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
163.60%
5Y dividend/share CAGR above 1.5x ADI's 55.15%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
79.57%
3Y dividend/share CAGR above 1.5x ADI's 37.06%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
18.37%
AR growth well above ADI's 15.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.00%
Inventory is declining while ADI stands at 3.79%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.37%
Asset growth above 1.5x ADI's 1.16%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.79%
BV/share growth above 1.5x ADI's 1.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.01%
Debt shrinking faster vs. ADI's 0.03%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
1.85%
R&D growth drastically higher vs. ADI's 3.32%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.50%
SG&A declining or stable vs. ADI's 8.45%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.